Patient Scenario 2: Second-Line Management of RR DTC With Cabozantinib
Moving on to a new clinical scenario, Lori Wirth, MD, reviews the second-line management of a patient who progresses on frontline systemic therapy.
Source: onclive.com
Stay updated with breaking news from Second Line Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moving on to a new clinical scenario, Lori Wirth, MD, reviews the second-line management of a patient who progresses on frontline systemic therapy.